Director of Epidemiology
Epividian, Inc.
Disclosure(s): EMD Serono: Research support to my employer; Gilead Sciences: Research support to my employer; Merck & Co.: Research support to my employer; TheraTechnologies: Research support to my employer; ViiV Healthcare: Research support to my employer
Rachel Palmieri Weber, PhD is a Director of Epidemiology at Epividian. While obtaining a BS in Psychology and Anthropology from the University of Pittsburgh (2001), she worked at the Panic, Anxiety, and Traumatic Grief Program at the University of Pittsburgh Medical Center, gaining valuable experience in mental health clinical trials. She then coordinated the 2005 North Carolina Women’s Health Report Card and earned a MSPH in Epidemiology at the University of North Carolina (UNC) at Chapel Hill (2006). Rachel further focused her training in women’s health on cancer epidemiology, working as the project and data manager for the Ovarian Cancer Association Consortium (OCAC) at Duke University while earning her PhD in Epidemiology at UNC (2015); she used data from fifteen OCAC studies in an individual participant data (IPD) meta-analysis of the association between hysterectomy and epithelial ovarian cancer for her doctoral dissertation. After graduate school, Rachel became the UNC program manager at the RTI-UNC Evidence-based Practice Center where she provided methodological expertise for systematic evidence reviews, comparative effectiveness reviews, and health technology assessments on screening, diagnosis, and treatment across a diverse range of therapeutic areas including cancer, infectious disease, mental health, and women’s health. Since joining the Epividian team in 2019, Rachel has gained experience in HIV-associated wasting, HCV, and clinical decision support systems that aim to improve retention in care, facilitate screening, and increase uptake of treatment.